Loading…
SciSparc Ltd. is projected to decline to $4.59 by 2027, a -2% move from its current price of $4.70. SPRC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.37 | $4.70 | $5.05 | -0.05% |
| Jul 14 | $4.24 | $4.70 | $5.20 | -0.10% |
| Jul 15 | $4.14 | $4.69 | $5.31 | -0.16% |
| Jul 16 | $4.06 | $4.69 | $5.41 | -0.21% |
| Jul 17 | $3.99 | $4.69 | $5.50 | -0.26% |
| Jul 18 | $3.93 | $4.69 | $5.59 | -0.31% |
| Jul 19 | $3.87 | $4.68 | $5.66 | -0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.87 | $4.68 | $5.66 | -0.36% |
| Week 2 | $3.57 | $4.67 | $6.10 | -0.73% |
| Week 3 | $3.35 | $4.65 | $6.46 | -1.09% |
| Week 4 | $3.17 | $4.63 | $6.77 | -1.45% |
| Week 5 | $3.02 | $4.62 | $7.05 | -1.80% |
| Week 6 | $2.89 | $4.60 | $7.32 | -2.16% |
| Week 7 | $2.77 | $4.58 | $7.57 | -2.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others.
It has agreements with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd.
and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
SciSparc Ltd. (SPRC) is a healthcare stock trading at $4.70 with a current market cap of $2.69M. It holds a rank of 5443 in market capitalization among global equities. The price outlook is mixed across the forecast horizon, with 2026 forecast avg $4.70 and 2030 avg $4.44, rising toward 2050 avg $13.39 with a 184.8 ROI and a bullish sentiment for the later period.
The maximum forecast price reaches $30.79 by 2050 in the upside scenario, while the 2033 max hits $10.94 and 2040 max $12.59.
A major floor 97.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 145.5% above — a clean break opens room to run.
A major ceiling 194.0% above — clearing it would confirm fresh momentum.
Key SPRC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SPRC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.07 | Sell | $5.10 | Sell |
| MA 10 | $5.21 | Sell | $5.42 | Sell |
| MA 20 | $6.38 | Sell | $6.06 | Sell |
| MA 50 | $6.88 | Sell | $6.53 | Sell |
| MA 100 | $5.76 | Sell | $8.07 | Sell |
| MA 200 | $13.66 | Sell | $20.87 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.93 | Neutral |
| Stoch RSI (14) | 22.67 | Neutral |
| CCI (20) | -89.60 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | -32.08 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.05 | Sell |
| Awesome (5,34) | -2.15 | Sell |
| Ultimate (7,14,28) | 29.73 | Buy |
| Momentum (10) | -1.42 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 5.20 | Sell |
| ADX (14) | 20.79 | Sell |
| ATR (14) | 0.47 | Info |
The 30-day technical picture is bearish. RSI14 is 40, and the stock trades below both key moving averages, with SMA50 at $6.88 and SMA200 at $13.66. The stock finds near-term support at $4.70 and resistance at $11.54. Over the past 30 days the price has ranged from a low of $2.93 to a high of $7.54. Annualized volatility sits at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.06 | $4.70 | $6.17 | 0% | Neutral | |
| $3.33 | $4.59 | $6.84 | -2% | Neutral | |
| $2.64 | $3.86 | $6.14 | -18% | Bearish | |
| $2.05 | $3.17 | $5.28 | -33% | Bearish | |
| $2.74 | $4.44 | $7.70 | -6% | Neutral | |
| $3.05 | $5.15 | $9.25 | +10% | Neutral | |
| $2.91 | $5.13 | $9.51 | +9% | Neutral | |
| $3.13 | $5.74 | $10.94 | +22% | Bullish | |
| $2.47 | $4.72 | $9.22 | 0% | Neutral | |
| $2.20 | $4.37 | $8.72 | -7% | Neutral | |
| $2.58 | $5.73 | $12.59 | +22% | Bullish | |
| $6.02 | $13.39 | $30.79 | +185% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.06 | $4.70 | $5.51 | +0.00% |
| August 2026 | $3.52 | $4.26 | $5.38 | -9.32% |
| September 2026 | $3.65 | $4.48 | $5.77 | +5.17% |
| October 2026 | $3.77 | $4.68 | $6.14 | +4.48% |
| November 2026 | $3.61 | $4.54 | $6.03 | -3.08% |
| December 2026 | $3.61 | $4.58 | $6.17 | +0.91% |
Click any year to see its month-by-month SPRC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SPRC to range from $3.06 to $6.17 through 2026. The $4.70 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SPRC price prediction for 2027 points to an average of $4.59 (low $3.33, high $6.84) — a potential decline of -2% on today's $4.70. Price action looks broadly range-bound.
In 2028, SPRC is projected to trade between $2.64 and $6.14, averaging $3.86 — a potential decline of -18% from today's $4.70. That is -16% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
SciSparc Ltd.'s 2029 outlook centres on $3.17, within a $2.05 to $5.28 range. That is -18% versus the projected 2028 average. That marks a -33% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, SPRC could reach as high as $7.70, with a base case around $4.44 and support toward $2.74 — roughly -6% from $4.70. A consolidation phase looks the most probable path here.
Expect SPRC to range from $3.05 to $9.25 through 2031. The $5.15 average target implies a +10% move from current prices. That is up +16% on the projected 2030 average. Price action looks broadly range-bound.
The SPRC price prediction for 2032 points to an average of $5.13 (low $2.91, high $9.51) — a potential gain of +9% on today's $4.70. A consolidation phase looks the most probable path here.
In 2033, SPRC is projected to trade between $3.13 and $10.94, averaging $5.74 — a potential gain of +22% from today's $4.70. That is up +12% on the projected 2032 average. Momentum favours further upside here.
SciSparc Ltd.'s 2034 outlook centres on $4.72, within a $2.47 to $9.22 range. That is -18% versus the projected 2033 average. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, SPRC could reach as high as $8.72, with a base case around $4.37 and support toward $2.20 — roughly -7% from $4.70. Price action looks broadly range-bound.
Expect SPRC to range from $2.58 to $12.59 through 2040. The $5.73 average target implies a +22% move from current prices. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SPRC price prediction for 2050 points to an average of $13.39 (low $6.02, high $30.79) — a potential gain of +185% on today's $4.70. Momentum favours further upside here.
Investing $1,000 in SPRC today (≈ 212.765957 SPRC) could be worth
$2,848.18
+$1,848.18 (+185%) by 2050 · US Dollar
Based on the average projected SPRC price of $13.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SPRCwould be worth at today's price.
$1,000 invested in SPRC on Jul 10, 2025 (≈ 16.079756 SPRC) would be worth
$75.57
-$924.43 (-92.4%) today · 0.08× · US Dollar
Based on a SPRC entry price of $62.19 vs. today's $4.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.78 | $983.26 | -1.7% |
| 1 month ago | $8.66 | $542.73 | -45.7% |
| 3 months ago | $3.15 | $1,492.06 | +49.2% |
| 6 months ago | $13.05 | $360.15 | -64.0% |
| 1 year ago | $62.19 | $75.57 | -92.4% |
| All time (4.9y) ago | $22,113 | $0.21 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SPRC forecast.
Our base-case forecast reaches $9.40 around 2050.
Implied market cap at $9.40: $5.39M
The multi-year forecast shows a mixed path with several turning points. For 2026, the avg forecast is $4.70 with a min of $3.06, a max of $6.17, ROI 0, sentiment NEUTRAL. By 2030 the avg is $4.44 with a min of $2.74, a max of $7.70, ROI -5.6, sentiment NEUTRAL.
In 2031 the avg rises to $5.15 (min $3.05, max $9.25; ROI 9.5; sentiment NEUTRAL) and in 2032 to $5.13 (min $2.91, max $9.51; ROI 9.3; sentiment NEUTRAL). The 2033 forecast shows an uptick to an avg of $5.74 (min $3.13, max $10.94; ROI 22.2; sentiment BULLISH). The 2034 forecast remains NEUTRAL with avg $4.72 (min $2.47, max $9.22; ROI 0.5).
By 2035 the avg is $4.37 (min $2.20, max $8.72; ROI -7.1; sentiment NEUTRAL). The 2040 forecast indicates a bullish stance with avg $5.73 (min $2.58, max $12.59; ROI 22; sentiment BULLISH). The long-range view through 2050 shows a strong upside, with an avg of $13.39 (min $6.02, max $30.79; ROI 184.8; sentiment BULLISH).
These figures reflect the projected volatility and do not guarantee future results.
Tap a question to reveal the answer.
2030 avg $4.44; min $2.74; max $7.70; ROI -5.6; sentiment NEUTRAL.
Forecasts show mixed signals: 2026 avg $4.70, 2027 avg $4.59, 2028 avg $3.86, 2029 avg $3.17, 2030 avg $4.44 with some negative ROI (e.g., -2.3 in 2027 and -32.6 in 2029). Later years show higher upside, including 2033 max $10.94 and 2050 max $30.79 with 184.8 ROI and bullish sentiment, but these are estimates and not guarantees.
Yes. The 2033 forecast max is $10.94 and the 2040 forecast max is $12.59, indicating potential to exceed $10.
Current price is $4.70 and market cap is $2.69M.
The max forecast price is $30.79 in 2050, with a min of $6.02 and avg $13.39.
SciSparc Ltd. Community Discussion
0Share your SciSparc Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.